Search Salaries, Companies, Skills and other Resources

Didn't find your job?

Companies

See how salaries can vary from company to company

As a responsible oil and gas producer, Vermilion Energy Inc. offers diverse opportunities and rewards for talented people who are committed to delivering superior results. Our quality assets in North America, Europe and Australia inspire our people to achieve their professional and personal best while contributing to a culture of safety and sustainability, and giving back to our local communities. Supported by a strong leadership team, our people have helped Vermilion earn recognition as one of the best workplaces in our locations around the world. These strong rankings reflect Vermilion's com... view company details

W&T Offshore, Inc., an independent oil and natural gas producer, engages in the acquisition, exploration, and development of oil and natural gas properties in the Gulf of Mexico. The company sells crude oil, natural gas liquids, and natural gas. It holds working interests in approximately 48 offshore fields in federal and state waters. The company also owns interests in approximately 123 offshore structures. It has interests in offshore leases covering approximately 390,000 net acres spanning across the Outer Continental Shelf off the coasts of Louisiana, Texas, Mississippi, and Alabama. As of... view company details

Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients with cancer and other diseases in North America, Europe, and the Asia Pacific. It provides BRAFTOVITM (encorafenib) capsules in combination with MEKTOVI (binimetinib) tablets for the treatment of patients with unresectable or metastatic melanoma with a BRAF mutation. The company's lead clinical programs include encorafenib and binimetinib that are investigated in approximately 30 clinical trials for various solid tumor indications, including ... view company details

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of various therapeutics in the United States. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera cancers; and Iclusig, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome positive acute lymphoblastic leukemia. Its clinical stage products include ruxolitinib, a drug in Phase III clinical trial for steroid-refractory acute graft-versus-host-diseases (GVHD); and Phase II trial for the treatment of essential thrombocythem... view company details

Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery. It is developing relacorilant that is in Phase III clinical trial to treat patients with Cushing's syndro... view company details

Trovagene, Inc., a clinical-stage, oncology therapeutic company, develops drugs to treat various types of cancer, including leukemia, lymphomas, and solid tumors. Its lead drug candidate is onvansertib, a Polo-like Kinase 1 selective adenosine triphosphate competitive inhibitor that is in Phase Ib/II clinical trial in acute myeloid leukemia (AML); has completed a Phase I clinical trial in advanced solid tumors; and Phase Ib/II clinical trial for metastatic Colorectal Cancer in combination with FOLFIRI and Avastin. The onvansertib is also in Phase II clinical trial in combination with Zytiga fo... view company details

At Codifyd, we transform the way B2B and B2B2C distributors and manufacturers leverage the digital landscape. With a product content-centric approach, we create a failsafe system for organizations to manage complex data and information required in today's digital commerce marketplace. Our digital transformation services and AI technologies enable operational efficiency for B2B and B2B2C organizations and their channel partners, while providing a superior research-to-purchase experience for end users and financial growth for sellers. view company details

Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology for the treatment of cancer and rare genetic diseases. The company offers TIBSOVO (ivosidenib), an oral targeted inhibitor for treating adult patients with relapsed or refractory acute myeloid leukemia (R/R AML), as well as to treat patients with newly diagnosed AML; and IDHIFA, an oral targeted inhibitor for patients with R/R AML and an isocitrate dehydrogenase 2 mutation. It is also developing TIBSOVO, which has comp... view company details

OncoSec Medical Incorporated, a biotechnology company, focuses on the development of cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target and attack cancer. Its lead product candidate is ImmunoPulse IL-12 that uses electroporation device to deliver a DNA-encoded interleukin-12 for reversing the immunosuppressive microenvironment in the treated tumor. The company is also developing ImmunoPulse IL-12 with KEYTRUDA in patients with advanced melanoma that is in the Phase IIb clinical trials (PISCES/KEYNOTE-695) and advanced or metastatic triple negative breas... view company details

Tyme Technologies, Inc., a clinical-stage biotechnology company, develops novel cancer therapeutics. It is developing SM-88, a combination therapy based on dysfunctional metyrosine derivatives in Phase II development for metastatic pancreatic cancer and biomarker-recurrent prostate cancer. The company was founded in 2011 and is headquartered in New York, New York. view company details

Control Concepts designs and manufactures digital scr power controllers for the semiconductor, solar, glass, and other manufacturing sectors that require precision power control. Our technical expertise includes low voltage AC, analog, digital, magnetics, and power electronics design. view company details

Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Its therapeutic candidates include luspatercept, which completed Phase III clinical trials for the treatment of myelodysplastic syndromes, beta-thalassemia, and myelofibrosis; Phase II clinical trials for the treatment of patients with transfusion-dependent beta-thalassemia. The company is also developing and sotatercept for the treatment of patients with pulmonary hypertension. In addition, the company is developing... view company details

Humanigen, Inc., a biopharmaceutical company, develops proprietary monoclonal antibodies for immunotherapy and oncology treatments. The company's lead product candidate is Lenzilumab, a monoclonal antibody that targets and neutralizes granulocyte-macrophage colony-stimulating factor, which is in Phase I/II clinical trial in patients with chronic myelomonocytic leukemia, and for the treatment of juvenile myelomonocytic leukemia. It also develops Ifabotuzumab, a monoclonal antibody that targets EphA3 receptor, which has completed the Phase I dose escalation portion of a Phase I/II clinical trial... view company details

Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company is involved in developing sitravatinib, a spectrum-selective kinase inhibitor, which is in Phase II clinical for the treatment of non-small cell lung cancer (NCSLC); and in Phase Ib clinical trial to treat NCSLC patients with Casitas B-lineage Lymphoma genetic alterations, as well as KRAS G12C inhibitor program for NSCLC adenocarcinoma patients, colorectal cancer patients, and other cancers. It also develops moc... view company details

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, develops and commercializes novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. Its MultiTAA T cell technology is based on the tumor-specific T cells that recognize tumor associated antigens and kill tumor cells expressing those targets. The company is developing TPIV100/110, which is in Phase II clinical trial to treat human epidermal growth factor receptor 2 breast cancer; and TPIV200 that is in Phase II clinical trial for the treatment of ... view company details

BASF SE is a German chemical company and the largest chemical producer in the world. The BASF Group comprises subsidiaries and joint ventures in more than 80 countries and operates six integrated production sites and 390 other production sites in Europe, Asia, Australia, the Americas and Africa. Its headquarters is located in Ludwigshafen, Germany. BASF has customers in over 190 countries and supplies products to a wide variety of industries. Despite its size and global presence, BASF has received relatively little public attention since it abandoned manufacturing and selling BASF-branded co... view company details

A.M. Castle & Co., together with its subsidiaries, operates as a specialty metals distribution company in the United States, Canada, Mexico, France, and internationally. The company distributes engineered specialty grades and alloys of metals, as well as offers specialized processing services. Its products include alloy, aluminum, stainless steel, nickel, carbon, and titanium in plate, sheet, extrusions, round bar, hexagon bar, square and flat bar, tubing, and coil forms. The company also performs various specialized fabrications for its customers through subcontractors, which thermally proces... view company details

Cirque du Soleil (French: [sɪʁk dzy sɔ.lɛj], "Circus of the Sun" or "Sun Circus") is a Quebecer entertainment company and the largest theatrical producer in the world. Based in Montreal, Quebec, Canada, and located in the inner-city area of Saint-Michel, it was founded in Baie-Saint-Paul on 7 July 1984, by two former street performers, Guy Laliberté and Gilles Ste-Croix. Initially named Les Échassiers ([lez‿e.ʃa.sje], "The Waders"), they toured Quebec in 1980 as a performing troupe. Their initial financial hardship was relieved in 1983 by a government grant from the Canada Council for the Art... view company details

Chicago White Metal Casting (CWM) is a custom producer of aluminum, magnesium, zinc and miniature zinc die castings. Founded in 1937, the company delivers high-tech, award-winning die castings worldwide to leading OEM manufacturers. Die casting design and production services include: * DFM evaluation * Magmasoft process simulation of die designs with CAD/CAM tooling construction * Various prototype options (in-house and other) * Process-controlled six-sigma die casting production * Advanced in-house CNC machining enabling delivery of components requiring post-casting operations * A full range ... view company details

U.S. Sugar is one of the nation's largest fully integrated producer of sugar cane, one of Florida's major producers of orange juice products and a regional short line railroad operator. Headquartered in Clewiston, Florida the company farms more than 180,000 acres in Hendry, Glades, and Palm Beach counties and employs approximately 1,700 people including many high skilled/wage jobs in automated environments.Produces 650,000 - 700,000 tons of cane sugar a year, providing nearly 8% of the nation's sugar production.United States Sugar Corporation employs approximately 300 people including high ski... view company details